Skip to main content
Robert Molokie, MD, Oncology, Chicago, IL

Robert E Molokie MD


Physician

Join to View Full Profile
  • 1740 W Taylor StChicago, IL 60612

  • Phone+1 866-600-2273

  • Fax+1 312-569-8114

Dr. Molokie is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Loyola University Medical Center
    Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1989
  • Cook County Health and Hospitals System
    Cook County Health and Hospitals SystemInternship, Internal Medicine, 1983 - 1984
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1983

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1985 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease
    Robert E. Molokie, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Risk Factors for Kidney Disease in Hb SC and Hb S_+-Thalassemia Sickle Cell Disease
    Robert E. Molokie, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Cancer Incidence in Sickle Cell Disease:an Institutional Experience 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Clinical, Laboratory, and Genetic Risk Factors for Thrombosis in Sickle Cell Disease 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • $7.1M Grant to Review Opioid Alternatives to Treating Sickle Cell Disease Pain
    $7.1M Grant to Review Opioid Alternatives to Treating Sickle Cell Disease PainOctober 5th, 2020
  • Genetic Variant Might Be a Better Marker for Heart Disease
    Genetic Variant Might Be a Better Marker for Heart DiseaseApril 11th, 2018
  • NIH Awards $4.6 Million for Chronic Pain Research
    NIH Awards $4.6 Million for Chronic Pain ResearchFebruary 26th, 2018
  • Join now to see all

Grant Support

  • Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease PainUNIVERSITY OF ILLINOIS AT CHICAGO2020–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: